Loss of CD20 Expression in Follicular Lymphoma after Program Anti-Tumor Therapy Including Rituximab: Literature Data and Case Report

Loss of CD20 Expression in Follicular Lymphoma after Program Anti-Tumor Therapy Including Rituximab: Literature Data and Case Report

It is the first description of a case of follicular lymphoma with a loss of CD20 antigen expression during the anti-tumor treatment including rituximab in the NN Blokhin Russian Cancer Research Center. The article discusses the tactics of further management of such patients and the effect of the CD2...

Full description

Bibliographic Details
Main Authors: OM Volodina, NA Kupryshina, NA Falaleeva, VA Doronin, AV Mozhenkova, MA Frenkel’, EN Sorokin, NV Kokosadze, NN Tupitsyn, GS Tumyan, EA Osmanov
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2017-04-01
Series:Kliničeskaâ onkogematologiâ
Subjects:
follicular lymphoma
CD20-negative
rituximab
Online Access:http://bloodjournal.ru/wp-content/uploads/2017/03/6.pdf

Internet

http://bloodjournal.ru/wp-content/uploads/2017/03/6.pdf

Similar Items